{{Rsnum
|rsid=916457
|Gene=DRD4
|Chromosome=11
|position=637014
|Orientation=plus
|GMAF=0.1024
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{PharmGKB
|RSID=rs916457
|Name_s=
|Gene_s=DRD4, SCT, CDHR5
|Feature=
|Evidence=PubMed ID:19238168
|Annotation=This variant along with 3 other SNPs near DRD4 (4 SNP haplotype: rs3758653; rs916457; rs762502; rs11246226) is associated with tardive dyskinesia in male schizophrenia patients.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia; tardive dyskinesia
|Curation Level=Curated
|PharmGKB Accession ID=PA164892187
}}

{{PMID|17089069|OA=1
}} Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}